Researchers refute textbook knowledge on macrophage metabolism in inflammatory diseases

March 17, 2016

What happens when macrophage immune cells are activated in the course of an inflammation to combat pathogens such as bacteria or viruses? Researchers of the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg pursued this very question. The researchers discovered that the immune cells behave differently from what was previously assumed. Their metabolism upholds the production of antimicrobial substances and fatty acids during activation. In this way, they deliver important resources for the immune responses they trigger.

By studying the metabolic reactions involved, the researchers have demonstrated a new approach for treating . "We were able to slow down inflammation by pharmacological means," explains Karsten Hiller, Head of the "Metabolomics" research group at LCSB. "There could be a new therapeutic approach here, say for handling allergies or ." The Luxembourg scientists' study is published in the Journal of Biological Chemistry.

Macrophages - also known as scavenger cells - are and, as such, are part of the innate immune system. They differentiate out from monocytes circulating in the blood stream and migrate into the surrounding tissue. Macrophages are activated when they come into contact with membrane components of bacteria and viruses, or with inflammatory messengers such as cytokines. They are then involved in the defence against the invading pathogen.

These activation processes are complex and trigger profound reprogramming of the macrophage metabolism. Detailed research on what exactly takes place in these processes had long been missing. One important actor in reprogramming is the protein Hif1?. This protein was already known from earlier studies of cancer cells. If the cells exist in an oxygen-poor environment - say in the middle of a tumour - then Hif1? is stabilised, in that its degradation is prevented. As a consequence, via a series of regulatory mechanisms, this ultimately causes less pyruvate to be introduced into the citric acid cycle - a crucial metabolic pathway in many life forms by which they produce energy and building materials for synthesising a whole host of molecules.

"It was known that Hif1 is stabilised in activated despite the presence of oxygen. So it was assumed that the other metabolic pathways were also similar to those in ," explains Dr. Johannes Meiser from the Metabolomics group at LCSB. "We have now shown that this is not the case: In macrophages, the introduction of pyruvate into the citric acid cycle is maintained despite the presence of Hif1?."

Macrophages thus allow continued production of itaconic acid, a kind of endogenous antibiotic. In an earlier work, researchers working with Prof. Hiller had shown for the first time that itaconic acid is indeed produced in mammals at all (DOI: 10.1073/pnas.1218599110). Synthesis of that are needed for macrophage growth can also continue in the course of the inflammatory response.

"Conversion of pyruvate is a pivotal step in the inflammatory event, and thus presents a starting point for developing anti-inflammatory therapies," Hiller says. "This would be helpful for diseases associated with an excessive inflammatory response, such as allergies or septic shock." The researchers have proven in experiments that this works in principle: When they blocked the influence of pyruvate in the citrus cycle, the inflammatory responses decreased.

Explore further: Researchers discover endogenous antibiotic in the brain

More information: Johannes Meiser et al. Pro-inflammatory Macrophages Sustain Pyruvate Oxidation through Pyruvate Dehydrogenase for the Synthesis of Itaconate and to Enable Cytokine Expression, Journal of Biological Chemistry (2016). DOI: 10.1074/jbc.M115.676817

Related Stories

Researchers discover endogenous antibiotic in the brain

May 6, 2013

Scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have discovered that immune cells in the brain can produce a substance that prevents bacterial growth: namely itaconic acid. ...

Protein NBS1 is crucial for macrophage functional activity

September 14, 2015

Protein NBS1, which plays a key role in DNA damage repair, is required for macrophage functional activity. This is one of the conclusions of a scientific paper published in the journal Blood by a team of experts from the ...

Recommended for you

Close up of the new mineral merelaniite

October 28, 2016

A team led by a physicist from Michigan Technological University has discovered a new mineral, named for the region in Tanzania where it comes from.

Self-sealing syringe prevents blood loss in hemophilic mice

October 28, 2016

(—For people whose blood does not clot appropriately, such as those with hemophilia, diabetes, or cancer, getting an injection or blood draw with a hypodermic needle is not a trivial matter. Because the needle ...

A composite thread that varies in rigidity

October 27, 2016

EPFL scientists have developed a new type of composite thread that varies in stiffness depending on its temperature. Applications range from multifunctional robots to knitted casts, and even tunable medical devices.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.